Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Lolland-Falster Health Study

NCT02482896 is registered in ClinicalTrials.gov with Region Sjælland as lead sponsor.

NCT NCT02482896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02482896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Lolland-Falster Health Study
Lead sponsor
Region Sjælland
Phase
Observational
Overall status
Unknown status
Start date
February 29, 2016
Completion date
December 31, 2019
Enrollment
25,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, chronic disease, coronary disease, disease, ear diseases, impaired health, mental disorders, nose diseases, personality, pharyngeal diseases, renal insufficiency, chronic, skin diseases, urinary incontinence, wellbeing